SHG:688247 - Sinotherapeutics Inc

Sinotherapeutics Inc. A
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q4	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	0% -	89.43% -	89.43% 0%	89.43% 0%	89.43% 0%	89.43% 0%	86.59% -3.2%
Net Margin	[friend]	[friend]	[friend]	[friend]	[friend]	26.2% 32.9%	22.8% -12.9%	42.77% 87.5%	45.07% 5.4%	48.12% 6.8%	52% 8.1%	37.54% -27.8%	3.39% -91.0%	3.73% 10.0%	4.07% 9.1%	4.63% 13.8%	20.67% 346.2%
Gross Margin	[friend]	[friend]	[friend]	[friend]	[friend]	85.43% 8.6%	80.99% -5.2%	78.13% -3.5%	77.93% -0.3%	73.15% -6.1%	75.56% 3.3%	71.23% -5.7%	35.32% -50.4%	35.12% -0.6%	35.25% 0.4%	36.54% 3.7%	52.7% 44.2%
Operating Margin	[friend]	[friend]	[friend]	[friend]	[friend]	36.78% 66.4%	31.54% -14.2%	38.12% 20.8%	40.15% 5.3%	37.61% -6.3%	39.77% 5.8%	27.28% -31.4%	6.51% -76.1%	6.46% -0.8%	6.42% -0.5%	7.72% 20.1%	19.77% 156.2%
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	95.1M 55.7%	310.28M 226.3%	315.47M 1.7%	317.59M 0.7%	287.17M -9.6%	271.19M -5.6%	247.56M -8.7%	226.8M -8.4%	230.47M 1.6%	274.02M 18.9%	299.87M 9.4%	368.86M 23.0%
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	785.31M -	799.59M 1.8%	865.81M 8.3%	880.97M 1.8%	914.8M 3.8%	1.3B 42.1%	1.33B 2.5%	1.33B -0.3%	1.35B 1.4%	1.35B 0.4%	1.36B 0.6%	1.35B -0.6%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	178.07M -	168.3M -5.5%	160.62M -4.6%	155.53M -3.2%	169.32M 8.9%	150.68M -11.0%	155.05M 2.9%	143.9M -7.2%	175.25M 21.8%	159.73M -8.9%	151.36M -5.2%	152.47M 0.7%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	607.24M -	631.29M 4.0%	705.19M 11.7%	725.44M 2.9%	745.48M 2.8%	1.15B 54.2%	1.18B 2.4%	1.18B 0.7%	1.17B -1.1%	1.19B 1.8%	1.21B 1.4%	1.2B -0.8%
Operating CashFlow	[friend]	[friend]	[friend]	[friend]	[friend]	17.9M -39.8%	-	145.77M -	125.46M -13.9%	116.42M -7.2%	-	73.18M -	-	64.12M -	-	12.96M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	398.99M -8.1%	247.33M -38.0%	433.95M 75.5%	398.99M -8.1%	247.33M -38.0%	187.51M -24.2%	511.65M 172.9%	289.55M -43.4%	166.65M -42.4%	756.67M 354.0%	763.15M 0.9%	449.79M -41.1%
End Cash Position	[friend]	[friend]	[friend]	[friend]	[friend]	247.33M -38.0%	187.51M -24.2%	511.65M 172.9%	293.53M -42.6%	164.9M -43.8%	754.19M 357.4%	763.15M 1.2%	446.8M -41.5%	380.03M -14.9%	140.92M -62.9%	641.78M 355.4%	227.33M -64.6%
Free Cash Flow	[friend]	[friend]	[friend]	[friend]	[friend]	12.37M -50.9%	20.35M 64.6%	129.77M 537.6%	82.28M -36.6%	24.06M -70.8%	47.57M 97.7%	-103.15M -	-68.06M -	-44.04M -	-51.97M -	-26M -	-18.63M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	24.91M 107.0%	-	134.92M -	143.14M 6.1%	138.17M -3.5%	-	92.94M -	-	75.52M -	-	61.07M -	-
Diluted Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	0.06 100%	0.173 189.0%	0.33 90.3%	0.35 6.1%	0.34 -2.9%	0.34 0%	0.22 -35.3%	0.19 -13.6%	0.17 -10.5%	0.16 -5.9%	0.13 -18.8%	0.16 23.1%
Return On Equity (%)	[friend]	[friend]	[friend]	[friend]	[friend]	4.1% -	11.21% 173.2%	21.29% 89.9%	19.73% -7.3%	20.43% 3.5%	15.84% -22.5%	9.87% -37.7%	8.42% -14.8%	7.88% -6.4%	5.97% -24.2%	5.12% -14.3%	6.39% 24.9%
Return On Assets (%)	[friend]	[friend]	[friend]	[friend]	[friend]	3.17% -	8.85% 179.0%	16.82% 90.0%	16.25% -3.4%	16.25% 0.0%	13.43% -17.4%	8.46% -37.0%	7.28% -14.0%	6.68% -8.2%	5.27% -21.1%	4.53% -14.0%	5.69% 25.4%